Medical Marketing and Media - Endo, Novartis begin agreement
Saturday, November 1st, 2008ENDO Pharmaceuticals has entered into a licensing agreement with Novartis to obtain the exclusive US marketing rights for Voltaren Gel (diclofenac sodium topical gel) 1%. Endo said it expects to commercialize Voltaren Gel using one of its two specialty sales forc…
